alcohol on glp 1 GLP-1 Use Reduction: Can It Really Help? GLP-1 Anti-Obesity Rx and Alcohol

Results of the ongoing Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease (FIGARO-DKD, NCT02545049) trial can be expected to shed further light on CV and HF outcomes

Recent Trends in GLP-1 Use and Spending in Medicare Ahead of the Trump administrations planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the availability of Medicares negotiated price for certain GLP-1 products beginning in 2027, new data from the Centers for Medicare & Medicaid Services (CMS) shows that use and spending for these drugs under Medicare has grown substantially in recent years, reflecting their demonstrated effectiveness at treating type 2 diabetes and other conditions

Get an Appointment Complete The Form Below And Well Get Back To You Immediately

Eli Lillys retatrutide (LY3437943), the leading triple agonist, advanced from promising phase 2 results into phase 3 trials

This will allow you to feel fuller for longer and curb cravings